TP53 Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia S Poulain, C Roumier, E Bertrand, A Renneville, A Caillault-Venet, ... Clinical Cancer Research 23 (20), 6325-6335, 2017 | 74 | 2017 |
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients MR Wilson, TA Eyre, AA Kirkwood, N Wong Doo, C Soussain, S Choquet, ... Blood, The Journal of the American Society of Hematology 139 (16), 2499-2511, 2022 | 61 | 2022 |
Discovery of candidate DNA methylation cancer driver genes H Pan, L Renaud, R Chaligne, J Bloehdorn, E Tausch, D Mertens, ... Cancer discovery 11 (9), 2266-2281, 2021 | 50 | 2021 |
Renal pathologic findings in TAFRO syndrome: is there a continuum between thrombotic microangiopathy and membranoproliferative glomerulonephritis? A case report and literature … A Leurs, V Gnemmi, A Lionet, L Renaud, JB Gibier, MC Copin, E Hachulla, ... Frontiers in immunology 10, 1489, 2019 | 31 | 2019 |
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia C Herbaux, C Kornauth, S Poulain, SJF Chong, MC Collins, R Valentin, ... Blood, The Journal of the American Society of Hematology 137 (25), 3495-3506, 2021 | 27 | 2021 |
Pomalidomide for multiple myeloma G Fouquet, C Bories, S Guidez, L Renaud, C Herbaux, S Javed, T Facon, ... Expert Review of Hematology 7 (6), 719-731, 2014 | 26 | 2014 |
Response to pneumococcal vaccination in multiple myeloma L Renaud, S Schraen, G Fouquet, S Guidez, H Demarquette, M Nudel, ... Cancer Medicine 8 (8), 3822-3830, 2019 | 24 | 2019 |
Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL). L Renaud, JB Bossard, B Carpentier, L Terriou, N Cambier, G Chanteau, ... European Journal of Haematology 107 (3), 2021 | 21 | 2021 |
Discontinuation of antimicrobial therapy in adult neutropenic haematology patients: a prospective cohort Z Van de Wyngaert, C Berthon, H Debarri, C Bories, S Bonnet, M Nudel, ... International journal of antimicrobial agents 53 (6), 781-788, 2019 | 21 | 2019 |
Incidence of central nervous system relapses in patients with DLBCL treated with lenalidomide as maintenance after R-CHOP S Bernard, H Ghesquieres, RO Casasnovas, S Griolet, M Gomes da Silva, ... Blood Advances 5 (15), 2965-2968, 2021 | 9 | 2021 |
Comprehensive molecular landscape in patients older than 80 years old diagnosed with acute myeloid leukemia: a study of the French Hauts-de-France AML observatory A RUNX | 8 | 2019 |
Outcomes of allogeneic hematopoietic cell transplantation (allo-HCT) for adults with primary mediastinal B cells lymphoma (PMBCL): a retrospective study on behalf of the … B Le Calvez, B Tessoulin, L Renaud, C Botella-Garcia, M Srour, ... Blood 138, 1826, 2021 | 7* | 2021 |
Heavy+ light chain analysis to assign myeloma response is analogous to the IMWG response criteria G Fouquet, KIE Snell, S Guidez, S Schraen, E Boyle, L Renaud, ... Leukemia & lymphoma 59 (3), 583-589, 2018 | 7 | 2018 |
De novo and secondary acute myeloid leukemia, real world data on outcomes from the French Nord-Pas-De-Calais Picardie acute myeloid leukemia observatory L Renaud, O Nibourel, C Berthon, C Roumier, C Rodriguez, C Frimat, ... Blood, The Journal of the American Society of Hematology 128 (22), 4013-4013, 2016 | 6 | 2016 |
Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trial L Brugières, N Cozic, R Houot, C Rigaud, D Sibon, J Arfi-Rouche, ... European Journal of Cancer 191, 112984, 2023 | 5 | 2023 |
Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis C Thieblemont, B Altmann, F Frontzek, L Renaud, L Chartier, N Ketterer, ... Blood Advances 7 (15), 3968-3977, 2023 | 4 | 2023 |
Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials SJ Juul, S Rossetti, M Kicinski, MAE van der Kaaij, F Giusti, P Meijnders, ... Acta Oncologica 62 (7), 744-752, 2023 | 4 | 2023 |
Le pomalidomide dans le myélome multiple G Fouquet, M Macro, O Decaux, C Fohrer, S Guidez, H Demarquette, ... La Revue de Médecine Interne 36 (9), 613-618, 2015 | 4 | 2015 |
Les gammapathies monoclonales de signification indéterminée ne nécessitent pas systématiquement un recours à une consultation spécialisée G Fouquet, K Amouzou, L Renaud, B Carpentier, A Simonnet, ... La Revue de médecine interne 36 (7), 444-449, 2015 | 4 | 2015 |
Employment situation among long-term Hodgkin lymphoma survivors in Europe: an analysis of patients from nine consecutive EORTC-LYSA trials SJ Juul, S Rossetti, M Kicinski, MAE van der Kaaij, F Giusti, P Meijnders, ... Journal of Cancer Survivorship 18 (3), 727-738, 2024 | 3 | 2024 |